Delving into the Latest Updates on Sichuan Shangrui Biopharmaceutical Co., Ltd. with Synapse

Overview

Tags

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

ACE x L-type calcium channel	1

[Translation] A randomized, double-blind, double-dummy, active-drug, parallel-controlled, multicenter clinical trial on the efficacy and safety of compound lisinopril tablets in the treatment of mild and moderate essential hypertension that is not effectively controlled by amlodipine besylate tablets alone

以苯磺酸氨氯地平片作为阳性对照，评价四川尚锐生物医药有限公司研发的复方赖诺普利片治疗轻、中度原发性高血压病患者的有效性和安全性。

[Translation]

Using amlodipine besylate tablets as a positive control, the efficacy and safety of compound lisinopril tablets developed by Sichuan Shangrui Biotechnology Co., Ltd. in the treatment of patients with mild and moderate essential hypertension were evaluated.

Start Date08 Mar 2023

Sponsor / Collaborator

Sichuan Shangrui Biopharmaceutical Co., Ltd.

CTR20213088

/ CompletedPhase 3

复方赖诺普利片治疗赖诺普利片单药治疗未有效控制的轻、中度原发性高血压病有效性及安全性随机、双盲双模拟、阳性药、平行对照、多中心临床试验

[Translation] A randomized, double-blind, double-dummy, active-drug, parallel-controlled, multicenter clinical trial on the efficacy and safety of compound lisinopril tablets in the treatment of mild and moderate essential hypertension that is not effectively controlled by lisinopril tablets alone

以赖诺普利片作为阳性对照，评价四川尚锐生物医药有限公司研发的复方赖诺普利片治疗轻、中度原发性高血压病患者的有效性和安全性。

[Translation]

Using lisinopril tablets as a positive control, the efficacy and safety of compound lisinopril tablets developed by Sichuan Shangrui Biotechnology Co., Ltd. in the treatment of patients with mild and moderate essential hypertension were evaluated.

Start Date21 Feb 2022

Sponsor / Collaborator

Sichuan Shangrui Biopharmaceutical Co., Ltd.

100 Clinical Results associated with Sichuan Shangrui Biopharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Sichuan Shangrui Biopharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Sichuan Shangrui Biopharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Sichuan Shangrui Biopharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 Sep 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

NDA/BLA

1

Login to view more data